Bristol Myers Squibb's Grammy campaign shows Sotyktu users comfortable in their own skin. The drug, approved by the FDA in September, treats plaque psoriasis. by Eric Berger. Health Canada's approval of SOTYKTU is based on data from the pivotal Phase 3 POETYK PSO-1 and POETYK PSO-2 clinical trials, which evaluated the safety and efficacy of SOTYKTU (6 mg once daily ... 1.) I don’t think this warrants the repulsion that y’all seem to have. Admittedly, this is not the Speedo I would’ve picked out for this guy - it’s too tight and too skimpy. They should’ve consulted with a gay dude 🙄. But he’s a fairly normal looking guy. If you get physically nauseous from seeing normal male bodies, you may need ... Posted by u/tarhawk71 - 1 vote and no commentsBristol Myers debuts first psoriasis drug ad on Grammys, leading chorus of pharma brands – Endpoints News. BMS' debut DTC campaign for psoriasis drug Sotyktu includes a TV ad, which ran on the...Black husbands/white blonde wives outnumbered anybody with a black woman about 20-to-1 when I was recording Madison Avenues commercial actors. Look at the new commercials more that the older ones. The NYC attitudes are very clear in video commercials. Posted: 5/10/2023 6:54:14 AM EST.The NEW IL-23 inhibitor from AbbVie indicated for the treatment of moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or p... SOTYKTU TV Commercials. We don't make the ads - We measure them. Sign up to track nationally aired TV ad campaigns for SOTYKTU. Competition for SOTYKTU includes and the other brands in the Pharmaceutical & Medical: Rx: Psoriasis, Shingles, Skin & Nails industry. You can connect with SOTYKTU on Facebook or by phone at 1-888-SOTYKTU. Deucravacitinib, sold under the brand name Sotyktu, is a medication used for the treatment of moderate-to-severe plaque psoriasis. It is a tyrosine kinase 2 (TYK2) inhibitor and it is taken by mouth. It was developed by Bristol Myers Squibb.. Deucravacitinib was approved for medical use in the United States in September 2022, and in Australia in December …SOTYKTU treatment was associated with an increase in the incidence of liver enzyme elevation compared to placebo. Evaluate liver enzymes at baseline and thereafter in patients with known or suspected liver disease according to routine management. If treatment-related increases in liver enzymes occur and drug-induced liver injury is suspected ...In the past 30 days, Speedo has had 4 airings and earned an airing rank of #3,440 with a spend ranking of #3,441 as compared to all other advertisers. Competition for Speedo includes JoS. A. Bank, Men's Wearhouse, Old Navy, Belk, The Good Feet Store and the other brands in the Retail Stores: Clothing & Footwear Stores industry.New Sotyktu Commercial. More skin. Television Commercial Enough, already. ... If it means they're getting rid of the one with the guy in the speedo I've got no issue with this one. ... That way, I know if the guy in the commercial is going to be overweight neanderthal in a banana hammock or a(n otherwise) nondescript guy dressed like a ...SOTYKTU treatment was associated with an increase in the incidence of liver enzyme elevation compared to placebo. Evaluate liver enzymes at baseline and thereafter in patients with known or suspected liver disease according to routine management. If treatment-related increases in liver enzymes occur and drug-induced liver injury is suspected ...Deucravacitinib, sold under the brand name Sotyktu, is a medication used for the treatment of moderate-to-severe plaque psoriasis. It is a tyrosine kinase 2 (TYK2) inhibitor and it is taken by mouth. It was developed by Bristol Myers Squibb.. Deucravacitinib was approved for medical use in the United States in September 2022, and in Australia in December …If you’re in the market for a commercial bus, buying a used one can be a cost-effective option. However, it’s crucial to thoroughly evaluate the condition of the bus before making ...The Sotyktu commercial ? This commercial grosses me out every single time. The premise is just moronic: meds have cleared a patch apparently on his belly where nobody would ever see it anyways. So he decides the best thing to do is stretch this red rubber band around himself, to then be sure people will stare at him ?References: 1. SOTYKTU [package insert]. Princeton, NJ: Bristol-Myers Squibb Company; 2022. 2. Armstrong AW, Gooderham M, Warren RB, et al. Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: efficacy and safety results from the 52-week, randomized, double-blinded, placebo-controlled phase 3 POETYK PSO-1 trial.Sotyktu Speedo commercial upvotes ... Do you get annoyed with a commercial you're seeing just a bit too much? Ever want to rip your ears off because of an ad jingle that just won't get out of your head? Tired of hearing the same three ads played while watching TV or browsing the internet? This is the place for you!Sotyktu is a brand-name biosimilar oral tablet that’s prescribed for plaque psoriasis. Sotyktu contains the active drug deucravacitinib. Sotyktu is FDA-approved to treat moderate to severe ...References: 1. SOTYKTU [package insert]. Princeton, NJ: Bristol-Myers Squibb Company; 2022. 2. Armstrong AW, Gooderham M, Warren RB, et al. Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: efficacy and safety results from the 52-week, randomized, double-blinded, placebo-controlled phase 3 POETYK PSO-1 trial.US dermatologists’ perceptions and experience with Sotyktu likely impacting their take on the entire TYK2 class for the treatment of plaque psoriasis.Exton, PA, Dec. 07, 2023 (GLOBE NEWSWIRE ...So clearly creepy. There's just something about the Sotyktu psoriasis commercial praising "the splendor of these thighs" as a guy dressed like a Roman soldier gets off a bus to some kind of gathering where all the soldiers salute each other with a fist to their chest. I feel the same sense of intruding on an intimate moment when I watch a sex ...Affective commercials don’t just sell us a great product; they also tell a story. People buy with their emotions before their logic, which makes advertisements that play on feeling...During the 0-to-52-week treatment period of the two clinical trials, PSO-1 and PSO-2 (total exposure of 986 patient-years with SOTYKTU), malignancies (excluding non-melanoma skin cancer) were reported in 3 subjects treated with SOTYKTU (0.3 per 100 patient-years), including single cases each of breast cancer, hepatocellular carcinoma, …Bristol Myers Squibb’s Sotyktu a first-in-class, oral, selective, allosteric tyrosine kinase 2 inhibitor, is the only approved TYK2 inhibitor worldwide and the first innovation in oral treatment ...Take 1 time every day. Can be taken with or without food. Do not crush, cut, or chew the SOTYKTU tablets. SOTYKTU is available as a 6 milligram (mg) pink, round pill. Each pill is marked with “BMS 895” and “6 mg.”. Do not take SOTYKTU if you are allergic to deucravacitinib or any of the ingredients in SOTYKTU.Marketing Stack Integrations and Multi-Touch Attribution. Real-Time Video Ad Creative Assessment. Check out SOTYKTU's 60 second TV commercial, 'The Feeling of Finding Your Back' from the Rx: …Sotyktu (deucravacitinib) treats psoriasis by selectively targeting the immune system by inhibiting tyrosine kinase 2 (TYK2), a member of the Janus kinase (JAK) family. Sotyktu is approved for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy.Feb 14, 2023 · Pharmaceutical advertising joins the Super Bowl with Bristol Myers Squibb’s SOTYKTU in a soul-baring spot edited by BANDIT. The ad was created by Humancare. SOTYKTU, the brand name for Deucravacitinib, treats moderate to severe plaque psoriasis in adults. In the spot, one woman finds confidence before a career-changing conference; meanwhile ... SOTYKTU™ is indicated for the treatment of moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy. Limitations of Use: SOTYKTU is not recommended for use in combination with other potent immunosuppressants. 2 DOSAGE AND ADMINISTRATION 2.1 Recommended Evaluations and Immunizations …The one-minute ad supports the Found It campaign for Sotyktu, a treatment for adults with moderate-to-severe plaque psoriasis. It’s a common immune affliction that causes rashes and itchy, dry patches of skin … If I hear a woman's voice exclaiming "she found it", I see if it's the woman in the old fashioned bathtub or the woman getting a spa treatment (this one). That way, I know if the guy in the commercial is going to be overweight neanderthal in a banana hammock or a(n otherwise) nondescript guy dressed like a gladiator. By Kate Taylor. March 9, 2016. Alex Breaux faced a twofold challenge in portraying Ray, a champion swimmer in the dark and twisty “Red Speedo” at New York Theater Workshop. He had to look ...The recommended dosage of SOTYKTU is 6 mg taken orally once daily, with or without food. Do not crush, cut, or chew the tablets. 2.3 Recommended Dosage in Patients with Hepatic Impairment . SOTYKTU is not recommended in patients with severe hepatic impairment (Child-Pugh C) [see Use in Specific Populations (8.7) and Clinical …BMS has previously said it reckons Sotyktu could become a $4 billion seller at its peak, fuelled by head-to-head studies showing it was more effective at treating moderate-to-severe psoriasis than ...We would like to show you a description here but the site won’t allow us.Video marketing. Power your marketing strategy with perfectly branded videos to drive better ROI. Event marketing. Host virtual events and webinars to increase engagement and generate leads. Employee communication. Inspire employees with compelling live and on-demand video experiences. Video monetization. Build a site and generate income from ...Take SOTYKTU exactly as your healthcare provider tells you to take it. Take SOTYKTU 1 time every day, with or without food. Do not crush, cut, or chew the SOTYKTU tablets. SOTYKTU may cause serious side effects, including: Changes in certain laboratory test results. Changes in laboratory tests have happened in some people taking SOTYKTU.What Is Sotyktu? Sotyktu is the first FDA-approved tyrosine kinase 2 (TYK2) inhibitor. It works by blocking the TYK2 protein, which is involved in processes that send signals to the skin that can trigger plaque psoriasis. The medication is currently the only option in its class — it is the only available treatment that works by blocking this ...Bristol Myers holds on to blockbuster Sotyktu hopes, plays down Otezla threat. By winning three first-in-class drug approvals, Bristol Myers Squibb certainly delivered on its plans in 2022 ...Sep 9, 2022 · Bristol Myers Squibb’s Sotyktu, a first-in-class, oral, selective, allosteric tyrosine kinase 2 (TYK2) inhibitor, is the only approved TYK2 inhibitor worldwide and the first innovation in oral treatment for moderate-to-severe plaque psoriasis in nearly 10 years Pivotal Phase 3 POETYK PSO clinical trials demonstrated superior efficacy of once-daily Sotyktu over placebo and twice-daily Otezla ... References: 1. SOTYKTU [package insert]. Princeton, NJ: Bristol-Myers Squibb Company; 2022. 2. Armstrong AW, Gooderham M, Warren RB, et al. Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: efficacy and safety results from the 52-week, randomized, double-blinded, placebo-controlled phase 3 POETYK PSO-1 trial. Pharmaceutical advertising joins the Super Bowl with Bristol Myers Squibb’s SOTYKTU® in a soul-baring spot edited by BANDIT. SOTYKTU®, the brand name for Deucravacitinib, treats moderate to severe plaque psoriasis in adults. Wave Making. It’s What Wave Makers Do. Join the team: us.speedo.comThe actor who plays the “Speedo Dad” in the cast of the 2023 Sotyktu commercial is Venezuelan actor Juan Carlos Liendo. Juan Carlos is an actor and TV host and has performed in many Latin American television projects over the last few years, like La Ley del Silencio and Love to Death . We would like to show you a description here but the site won’t allow us. A treatment for adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy has been approved by the U.S. Food and Drug Administration (FDA). Bristol Myers Squibb made the announcement today (September 12) that its allosteric tyrosine kinase 2 (TYK2) inhibitor, Sotyku ( …Black husbands/white blonde wives outnumbered anybody with a black woman about 20-to-1 when I was recording Madison Avenues commercial actors. Look at the new commercials more that the older ones. The NYC attitudes are very clear in video commercials.This randomized, double‐blind, single‐ and multiple‐ascending dose study assessed the pharmacokinetics (PKs), pharmacodynamics, and safety of deucravacitinib (Sotyktu™), a selective and potent small‐molecule inhibitor of tyrosine kinase 2, in 100 (75 active, 25 placebo) healthy volunteers (NCT02534636).Deucravacitinib was rapidly …Click "2024 Rules" in the top left corner under our icon, or See More > Menu for App users, to view our updated rules. Now get in the comments and rant and rave about those annoying commercials you just can't stand! The Sotyktu Speedo Guy has returned. Ze goggles do nozing!Posted by u/tarhawk71 - 1 vote and no commentsThe actor who plays the “Speedo Dad” in the cast of the 2023 Sotyktu commercial is Venezuelan actor Juan Carlos Liendo. Juan Carlos is an actor and TV … Deucravacitinib. Deucravacitinib, sold under the brand name Sotyktu, is a medication used for the treatment of moderate-to-severe plaque psoriasis. [7] It is a tyrosine kinase 2 (TYK2) inhibitor and it is taken by mouth. [7] It was developed by Bristol Myers Squibb. [10] Feb 14, 2023 · But the ridiculous guy in the red Spedo trunks in the Sotyktu commercial really isn't helping to sell the medication. Just sayin'. 12:22 AM · Feb 14, 2023 ... Click "2024 Rules" in the top left corner under our icon, or See More > Menu for App users, to view our updated rules. Now get in the comments and rant and rave about those annoying commercials you just can't stand! The Sotyktu Speedo Guy has returned. Ze goggles do nozing!Sotyktu is the first of its kind once-daily pill for moderate to severe plaque psoriasis for the chance at clear or almost clear skin. It's like the feeling of finding your back is back or finding psoriasis. Can't deny the splendor of these thighs. Once daily Sotyktu is proven to get more people clearer skin than the leading pill.SOTYKTU is a tyrosine kinase 2 (TYK2) inhibitor indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. (1) Limitations of Use : Not recommended for use in combination with other potent immunosuppressants.The recommended dosage of SOTYKTU is 6 mg taken orally once daily, with or without food. Do not crush, cut, or chew the tablets. 2.3 Recommended Dosage in Patients with Hepatic Impairment . SOTYKTU is not recommended in patients with severe hepatic impairment (Child-Pugh C) [see Use in Specific Populations (8.7) and Clinical …Bristol Myers Squibb won approval for Sotyktu in plaque psoriasis 11 months ago and began promoting the medicine in a TV spot at the Grammy Awards early this year. Now, the company is back with a...Apache/2.2.34 (Amazon) Server at cafepharma.com Port 80A non-commercial vehicle is a vehicle that is used strictly for transportation purposes. An example of a non-commercial vehicle is a family car, van or SUV. A non-commercial vehicl...SOTYKTU is a tyrosine kinase 2 (TYK2) inhibitor indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. (1) Limitations of Use : Not recommended for use in combination with other potent immunosuppressants.References: 1. SOTYKTU [package insert]. Princeton, NJ: Bristol-Myers Squibb Company; 2022. 2. Armstrong AW, Gooderham M, Warren RB, et al. Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: efficacy and safety results from the 52-week, randomized, double-blinded, placebo-controlled phase 3 POETYK PSO-1 trial. In the past 30 days, Speedo has had 4 airings and earned an airing rank of #3,440 with a spend ranking of #3,441 as compared to all other advertisers. Competition for Speedo includes JoS. A. Bank, Men's Wearhouse, Old Navy, Belk, The Good Feet Store and the other brands in the Retail Stores: Clothing & Footwear Stores industry. PHONE:1-888-SOTYKTU (1-888-768-9588) FAX: 1-888-381-0029 www.SOTYKTU.com Page 2 of 4 Please see US Full Prescribing Information and Medication Guide at www.SOTYKTU.com. Patient Authorization & Agreement The patient support program for SOTYKTU (deucravacitinib) (the “Program”) isDeucravacitinib. Deucravacitinib, sold under the brand name Sotyktu, is a medication used for the treatment of moderate-to-severe plaque psoriasis. [7] It is a tyrosine kinase 2 (TYK2) inhibitor and it is taken by mouth. [7] It was developed by Bristol Myers Squibb. [10]YOU CAN GET STARTED WITH THESE 3 STEPS: STEP 1: Complete your enrollment form to learn how you may be able to access therapy and affordability options for eligible patients, including the SOTYKTU Co-Pay Assistance Program. STEP 2: Answer the phone callfrom your dedicated SOTYKTU Support Coordinator. STEP 3: Set up your first …Sotyktu contains the active ingredient deucravacitinib. (An active ingredient is what makes a drug work.) Sotyktu belongs to a group of drugs called tyrosine kinase 2 blockers. It’s a biologic ...The actor who plays the “Speedo Dad” in the cast of the 2023 Sotyktu commercial is Venezuelan actor Juan Carlos Liendo. Juan Carlos is an actor and TV …I am so grateful for this service and their know-how. An old car should have a working odometer - the most fun to see those miles click up and up and up! Commercial Speedometer was able to quickly diagnose and fix the problem, and very affordably. A quick and easy stop drop-off and pick-up. A very family oriented place, and trustworthy.Feb 14, 2023 · Pharmaceutical advertising joins the Super Bowl with Bristol Myers Squibb’s SOTYKTU in a soul-baring spot edited by BANDIT. The ad was created by Humancare. SOTYKTU, the brand name for Deucravacitinib, treats moderate to severe plaque psoriasis in adults. In the spot, one woman finds confidence before a career-changing conference; meanwhile ... The first Speedo brief came in 17.5cm, 12.5cm and 7.5cm widths. “It was designed quite practically, not with fashion in mind,” he later recalled. “I realised you shouldn’t have anything ...I am so grateful for this service and their know-how. An old car should have a working odometer - the most fun to see those miles click up and up and up! Commercial Speedometer was able to quickly diagnose and fix the problem, and very affordably. A quick and easy stop drop-off and pick-up. A very family oriented place, and trustworthy.Sotyktu -- the red Speedo . Don't think any explanation is required. comments sorted by Best Top New Controversial Q&A Add a Comment. More posts you may like ... I hate any commercial that uses an existing song. It’s even worse when they force the product into the lyrics. Like Ozempic using Pilot’s song “Magic” Sotyktu is a tyrosine kinase 2 (TYK2) inhibitor indicated for the treatment of adults with moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy. Sotyktu is not recommended for use in combination with other potent immunosuppressants. Adalimumab is indicated for RA: reducing signs and symptoms, inducing ... Feb 13, 2023 · This #Sotyktu commercial is gross. No one wants to see a dudes belly hanging over a red Speedo. No one wants to see a dudes belly hanging over a red Speedo. Hope their product is better than this ad. SOTYKTU is the first and only approved TYK2 inhibitor in Canada and represents an important milestone in oral treatment for moderate to severe plaque psoriasis in nearly eight years . MONTREAL ...John Hoogenakker. Actor: Dopesick. In 2021, acclaimed actor John Hoogenakker can be seen starring in Hulu's limited series "Dopesick" opposite Michael Keaton, Peter Sarsgaard, Kaitlyn Dever, and Rosario Dawson. Inspired by the New York Times bestselling book by Beth Macy, "Dopesick" takes viewers to the epicenter of America's struggle with opioid addiction, from the boardrooms of Purdue Pharma ...A commercial real estate loan is most commonly used to purchase and/or renovate an owner-occupied commercial property. Business Financing | What is WRITTEN BY: Matthew Sexton Publi...
The deal made deucravacitinib, which is now sold as Sotyktu, the focus of BMS’ work on psoriasis. BMS won FDA approval in 2022 and racked up (PDF) sales of $170 million globally last year.. P088b allison code
Need a commercial real estate agent in New York City? Read reviews & compare projects by leading commercial real estate companies. Find a company today! Development Most Popular Em... 30 likes, 1 comments - theresonlyone_keaton on February 13, 2023: "This guy in the Sotyktu commercial is so hot. He could definitely be my “DADDY!” #sotyktu #so..." Keaton F. Baker on Instagram: "This guy in the Sotyktu commercial is so hot. We would like to show you a description here but the site won’t allow us.Take 1 time every day. Can be taken with or without food. Do not crush, cut, or chew the SOTYKTU tablets. SOTYKTU is available as a 6 milligram (mg) pink, round pill. Each pill is marked with “BMS 895” and “6 mg.”. Do not take SOTYKTU if you are allergic to deucravacitinib or any of the ingredients in SOTYKTU.SOTYKTU™ is indicated for the treatment of moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy. Limitations of Use: SOTYKTU is not recommended for use in combination with other potent immunosuppressants. 2 DOSAGE AND ADMINISTRATION 2.1 Recommended Evaluations and Immunizations Prior to Treatment Deucravacitinib. Deucravacitinib, sold under the brand name Sotyktu, is a medication used for the treatment of moderate-to-severe plaque psoriasis. [7] It is a tyrosine kinase 2 (TYK2) inhibitor and it is taken by mouth. [7] It was developed by Bristol Myers Squibb. [10] Deucravacitinib. Deucravacitinib, sold under the brand name Sotyktu, is a medication used for the treatment of moderate-to-severe plaque psoriasis. [7] It is a tyrosine kinase 2 (TYK2) inhibitor and it is taken by mouth. [7] It was developed by Bristol Myers Squibb. [10] If I hear a woman's voice exclaiming "she found it", I see if it's the woman in the old fashioned bathtub or the woman getting a spa treatment (this one). That way, I know if the guy in the commercial is going to be overweight neanderthal in a banana hammock or a(n otherwise) nondescript guy dressed like a gladiator. The deal made deucravacitinib, which is now sold as Sotyktu, the focus of BMS’ work on psoriasis. BMS won FDA approval in 2022 and racked up (PDF) sales of $170 million globally last year.Bristol Myers debuts first psoriasis drug ad on Grammys, leading chorus of pharma brands – Endpoints News. BMS' debut DTC campaign for psoriasis drug Sotyktu includes a TV ad, which ran on the...Sotyktu Commercial (2023)May 22, 2023 · Check out SOTYKTU's 60 second TV commercial, 'The Feeling of Finding Your Back' from the Rx: Psoriasis, Shingles, Skin & Nails industry. Keep an eye on this page to learn about the songs, characters, and celebrities appearing in this TV commercial. Share it with friends, then discover more great TV commercials on iSpot.tv. Published. May 22, 2023. BANDIT's Zeke O’Donnell cuts pharmaceutical spot created by Humancare. Pharmaceutical advertising joins the Super Bowl with Bristol Myers Squibb’s SOTYKTU in a soul-baring spot edited by BANDIT. The ad was created by Humancare. SOTYKTU, the brand name for Deucravacitinib, treats moderate to severe plaque psoriasis in adults.When planning for a commercial construction project, estimating the costs accurately is crucial. One tool that can greatly assist in this process is a commercial building cost calc...References: 1. SOTYKTU [package insert]. Princeton, NJ: Bristol-Myers Squibb Company; 2022. 2. Armstrong AW, Gooderham M, Warren RB, et al. Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: efficacy and safety results from the 52-week, randomized, double-blinded, placebo-controlled phase 3 POETYK PSO-1 trial.Pharmaceutical advertising joins the Super Bowl with Bristol Myers Squibb’s SOTYKTU® in a soul-baring spot edited by BANDIT. SOTYKTU®, the brand name for Deucravacitinib, treats moderate to severe plaque psoriasis in adults. In the spot, one woman finds confidence before a career-changing conference; meanwhile, her husband finds his own …What Is Sotyktu? Sotyktu is the first FDA-approved tyrosine kinase 2 (TYK2) inhibitor. It works by blocking the TYK2 protein, which is involved in processes that send signals to the skin that can trigger plaque psoriasis. The medication is currently the only option in its class — it is the only available treatment that works by blocking this ...We would like to show you a description here but the site won’t allow us.The deal made deucravacitinib, which is now sold as Sotyktu, the focus of BMS’ work on psoriasis. BMS won FDA approval in 2022 and racked up (PDF) sales of $170 million globally last year..
Popular Topics
- Ge washer water level resetBedpage santa ana
- Jeff doucet shooting videoYashahime season 3 release date
- Salvation army warsaw moLake george live cam
- Georgetown ca weatherHow to apply for intermittent leave walmart
- Unexpected win crossword clue 5 lettersWeis markets shippensburg
- Oreillys auto parts jasper tn7925 american way groveland fl 34736
- Hillcrest chapel newnan gaHusson family medicine bangor maine